Malignant pleural effusion (MPE) is an exudative effusion with malignant cells. MPE is a
common symptom and accompanying manifestation of metastatic disease. It affects up to …

It is now widely established that management of lung cancer is much more complex and
cannot be centered on the binary classification of small-cell versus non-small cell lung …

This overview of the molecular pathology of lung cancer includes a review of the most
salient molecular alterations of the genome, transcriptome, and the epigenome. The insights …

Extracellular vesicles (EV) are secreted by all cells, including cancer cells, as a mode of
intercellular transport and communication. The main types of EV known to date include …

Malignant pleural mesothelioma (MPM) is a rare, aggressive cancer of the mesothelial cells
lining the pleural surface of the chest wall and lung. The etiology of MPM is strongly …

The epigenetic role of microRNAs is established at both physiological and pathological
levels. Dysregulated miRNAs and their targets appear to be a promising approach for …

Objective Malignant mesothelioma is an aggressive cancer of the serous membranes. For
the detection of the tumor at early stages non-or minimally-invasive biomarkers are needed …

Malignant mesothelioma (MM) is a cancer of the mesothelial lining of the pleura,
peritoneum, pericardium and testes. The most common form is asbestos-linked MM that is …

Objectives A number of key immune regulators show prognostic value in malignant pleural
mesothelioma (MPM), but the association between Bridging integrator 1 (BIN1), indoleamine …

Simple Summary Pleural mesothelioma, a fatal thoracic cancer with one of the poorest
survival rates of any cancer, is in urgent clinical need for biomarkers to aid early diagnosis …